| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.91B | 51.38B | 50.62B | 48.62B | 43.77B | 34.52B |
| Gross Profit | 10.26B | 11.43B | 10.02B | 10.41B | 8.83B | 9.08B |
| EBITDA | 1.86B | 2.33B | 1.42B | 2.95B | 934.87M | 2.37B |
| Net Income | -355.72M | 2.46B | -435.33M | 1.00B | -1.55B | 431.07M |
Balance Sheet | ||||||
| Total Assets | 34.65B | 39.41B | 37.40B | 36.09B | 36.90B | 31.78B |
| Cash, Cash Equivalents and Short-Term Investments | 4.76B | 4.59B | 3.44B | 3.19B | 3.68B | 4.15B |
| Total Debt | 15.80B | 13.60B | 16.59B | 15.68B | 16.30B | 14.30B |
| Total Liabilities | 25.36B | 27.13B | 27.30B | 26.28B | 28.19B | 22.05B |
| Stockholders Equity | 9.29B | 12.28B | 10.09B | 9.80B | 8.70B | 9.74B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.64B | 535.81M | 748.94M | -1.98B | 278.94M |
| Operating Cash Flow | 0.00 | 4.01B | 849.97M | 1.37B | -1.27B | 1.03B |
| Investing Cash Flow | 0.00 | 131.92M | -955.47M | -835.12M | -864.45M | -4.59B |
| Financing Cash Flow | 0.00 | -3.18B | 141.48M | -1.50B | 1.52B | -789.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥19.43T | 43.64 | 12.80% | 0.78% | 10.40% | 11.67% | |
77 Outperform | ¥357.86B | 30.43 | ― | 1.49% | 8.80% | 8.09% | |
76 Outperform | ¥362.88B | 16.36 | ― | 2.04% | -8.82% | 18.33% | |
72 Outperform | ¥124.16B | 15.16 | ― | 3.02% | -5.84% | -10.06% | |
70 Outperform | ¥14.49B | 5.88 | 1.75% | 0.97% | 1.49% | ― | |
68 Neutral | ¥468.06B | 36.83 | 5.63% | 2.35% | -3.24% | -36.64% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |